Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban

BACKGROUND: Direct oral anticoagulants (DOAC) including edoxaban are increasingly used for stroke prevention in atrial fibrillation. Despite treatment, annual stroke rate in these patients remains 1–2%. Rapid assessment of coagulation would be useful to guide thrombolysis or reversal therapy in this...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neurol Res Pract
Auteurs principaux: Härtig, Florian, Birschmann, Ingvild, Peter, Andreas, Hörber, Sebastian, Ebner, Matthias, Sonnleitner, Matthias, Spencer, Charlotte, Bombach, Paula, Stefanou, Maria-Ioanna, Tünnerhoff, Johannes, Mengel, Annerose, Kuhn, Joachim, Ziemann, Ulf, Poli, Sven
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919064/
https://ncbi.nlm.nih.gov/pubmed/33641678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42466-021-00105-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires